Cargando…

A Hybrid Algorithm of ML and XAI to Prevent Breast Cancer: A Strategy to Support Decision Making

SIMPLE SUMMARY: Breast cancer is one of the most common health problems in the world. As a result, governments and researchers in different countries are trying to help prevent the disease. In this work, we develop a clinical decision support methodology based on machine learning tools. This methodo...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Aravena, Fabián, Núñez Delafuente, Hugo, Gutiérrez-Bahamondes, Jimmy H., Morales, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177162/
https://www.ncbi.nlm.nih.gov/pubmed/37173910
http://dx.doi.org/10.3390/cancers15092443
Descripción
Sumario:SIMPLE SUMMARY: Breast cancer is one of the most common health problems in the world. As a result, governments and researchers in different countries are trying to help prevent the disease. In this work, we develop a clinical decision support methodology based on machine learning tools. This methodology helps identify breast cancer patients and determine the risk factors for this disease. In addition, the proposed strategy can help detect the disease in its early stages using modern easy-to-interpret machine learning tools. ABSTRACT: Worldwide, the coronavirus has intensified the management problems of health services, significantly harming patients. Some of the most affected processes have been cancer patients’ prevention, diagnosis, and treatment. Breast cancer is the most affected, with more than 20 million cases and at least 10 million deaths by 2020. Various studies have been carried out to support the management of this disease globally. This paper presents a decision support strategy for health teams based on machine learning (ML) tools and explainability algorithms (XAI). The main methodological contributions are: first, the evaluation of different ML algorithms that allow classifying patients with and without cancer from the available dataset; and second, an ML methodology mixed with an XAI algorithm, which makes it possible to predict the disease and interpret the variables and how they affect the health of patients. The results show that first, the XGBoost Algorithm has a better predictive capacity, with an accuracy of 0.813 for the train data and 0.81 for the test data; and second, with the SHAP algorithm, it is possible to know the relevant variables and their level of significance in the prediction, and to quantify the impact on the clinical condition of the patients, which will allow health teams to offer early and personalized alerts for each patient.